Brunaud, Carole
Valable, Samuel
Ropars, Gwenn
Dwiri, Fatima-Azzahra
Naveau, Mikaël
Toutain, Jérôme
Bernaudin, Myriam
Freret, Thomas
Léger, Marianne
Touzani, Omar
Pérès, Elodie A.
Funding for this research was provided by:
Région Normandie (RIN 3R (2018-2021), RIN TORAL (2018-2021))
Centre National de la Recherche Scientifique
Université de Caen Normandie
Ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation
Agence Nationale de la Recherche (Investissement d’Avenir (n°ANR-10-EQPX1401))
Cancéropôle Nord-Ouest (Projet Emergence 2017)
Institut National Du Cancer (INCA_16071 (Brain-Matrix project))
Advanced Resource Center for HADrontherapy in Europe
Article History
Received: 26 February 2024
Accepted: 27 June 2024
First Online: 18 July 2024
Declarations
:
: All authors certify to comply with the ethical guidelines for authorship and publishing in Cancer Imaging. This animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Animal investigations performed in this study is in accordance with the current European directive (2010/63/EU). Ethical approval was obtained from the regional committee (CENOMEXA) and the French Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation (APAFIS #00919).
: Not applicable.
: The authors declare no competing interests.